HBM Healthcare Investments

Funding rounds backed by HBM Healthcare Investments.

Export CSV
Funding disclosed in full
$130M
Median round
$130M
Rounds in calculation
1
1 round
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Crystalys Therapeutics

Crystalys Therapeutics develops dotinurad, an oral URAT1 inhibitor for treating gout

$130MSeries BBiotechUnited States
10 participantsCormorant Asset ManagementFrazier Life SciencesHBM Healthcare InvestmentsKCap Biotechnology FundNovo HoldingsPivotal bioVenture PartnersSoleus CapitalSR OneTrails Edge Capital PartnersWellington Management